Terms: = Colorectal cancer AND TAL2, Q16559, 6887 AND Treatment
1 results:
1. Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa-miR-6887-3p.
Li H; Liang J; Wang J; Han J; Li S; Huang K; Liu C
Cancer Commun (Lond); 2021 Jun; 41(6):472-491. PubMed ID: 33638620
[TBL] [Abstract] [Full Text] [Related]
